You have 9 free searches left this month | for more free features.

PID

Showing 1 - 25 of 569

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tool for Primary Immunodeficiency Disease (PID) in Pakistan

Not yet recruiting
  • Primary Immunodeficiency Diseases
  • Primary Immunodeficiency (PID) Rapid Diagnostic Test (RDT)
  • Karachi, Pakistan
    Aga Khan University Hospital
Feb 24, 2023

Primary Immunodeficiency Diseases (PID) Trial (TAK-771)

Not yet recruiting
  • Primary Immunodeficiency Diseases (PID)
  • (no location specified)
Aug 22, 2022

Test: A Performance Study With Primary Immunodeficiency Tunisia

Not yet recruiting
  • Primary Immunodeficiency Diseases
  • IgG deficiency rapid screening test
  • Tunis, Tunisia
    National Bone Marrow Transplant center
Nov 10, 2022

At-Home Subcutaneous Immunoglobulin Replacement Therapy Using

Not yet recruiting
  • Primary Immunodeficiency Diseases (PID)
  • No Intervention
  • (no location specified)
Nov 21, 2023

Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety

Recruiting
  • Primary Immunodeficiency Diseases (PID)
  • Moscow, Russian Federation
    Dmitry Rogachev National Research Center of Pediatric Hematology
Aug 8, 2023

Primary Immune Deficiency Trial in Suresnes (MRI procedure)

Recruiting
  • Primary Immune Deficiency
  • MRI procedure
  • Suresnes, France
    Foch hospital
Jul 25, 2022

Pelvic Inflammatory Disease Trial in Baltimore (Tech-PN)

Recruiting
  • Pelvic Inflammatory Disease
  • Tech-PN
  • Baltimore, Maryland
    Johns Hopkins School of Medicine
Feb 8, 2022

Psychiatric Disorders Trial in Tienen, Heerlen (PID-5-BF+M and LPFS-BF 2.0 (self-report questionnaires), Secondary

Recruiting
  • Psychiatric Disorders
  • PID-5-BF+M and LPFS-BF 2.0 (self-report questionnaires)
  • +3 more
  • Tienen, Vlaams-Brabant, Belgium
  • +1 more
Nov 4, 2022

Primary Immunodeficiency Diseases (PID) Trial (TAK-881)

Not yet recruiting
  • Primary Immunodeficiency Diseases (PID)
  • TAK-881
  • (no location specified)
Oct 4, 2023

Cervical Cancer Trial in Japan, Spain, United States (M7824, Carboplatin, Paclitaxel)

Completed
  • Cervical Cancer
  • Stanford, California
  • +12 more
Jan 27, 2023

Lung Cancer, Cancer Trial in Rockland, Darmstadt, Madrid (Bintrafusp alfa)

Recruiting
  • Lung Cancer
  • Cancer
  • Bintrafusp alfa
  • Rockland, Massachusetts
  • +2 more
Dec 22, 2021

Primary Immune Deficiency, COVID Trial in Paris

Recruiting
  • Primary Immune Deficiency
  • COVID
    • Paris, France
      Imagine Institute
    Sep 1, 2021

    Primary Immunodeficiency Diseases (PID) Trial in Japan (Immune Globulin Intravenous (IGIV), Immune Globulin Subcutaneous, 20%

    Completed
    • Primary Immunodeficiency Diseases (PID)
    • Immune Globulin Intravenous (IGIV)
    • Immune Globulin Subcutaneous, 20% Solution (IGSC, 20%)
    • Nagoya-shi, Aichi, Japan
    • +7 more
    Feb 23, 2022

    Conducted in Poland to Document Management and Clinical Outcome

    Completed
    • Primary Immunodeficiencies (PID)
      • Gdańsk, Poland
      • +4 more
      Nov 15, 2021

      Incontinence-associated Dermatitis Trial in Berlin (ESENTA™ Skin Barrier Spray (ConvaTec, UK), Hydrophobes Basisgel DAC)

      Recruiting
      • Incontinence-associated Dermatitis
      • ESENTA™ Skin Barrier Spray (ConvaTec, UK)
      • Hydrophobes Basisgel DAC
      • Berlin, Germany
        Charité Universitätsmedizin Berlin
      Oct 28, 2022

      Primary Immunodeficiency Diseases (PID) Trial (TAK-881, HYQVIA)

      Not yet recruiting
      • Primary Immunodeficiency Diseases (PID)
      • TAK-881
      • HYQVIA
      • (no location specified)
      Feb 23, 2023

      Primary Immunodeficiency Disease Trial in United States (Kedrion IVIG 10%)

      Completed
      • Primary Immunodeficiency Disease
      • Kedrion IVIG 10%
      • North Palm Beach, Florida
      • +10 more
      Jan 26, 2022

      Subcutaneous Immunoglobulin in Primary and Secondary

      Not yet recruiting
      • Primary Immune Deficiency Disorder
      • Secondary Immune Deficiency
      • Edmonton, Alberta, Canada
        University of Alberta
      Jun 14, 2022

      Primary Immunodeficiency Disease Trial in Japan (IGSC 20% infusion)

      Active, not recruiting
      • Primary Immunodeficiency Disease
      • IGSC 20% infusion
      • Nagoya, Aichi, Japan
      • +7 more
      Jan 4, 2023

      Primary Immunodeficiency Diseases (PID) Trial in United States (Immune Globulin Intravenous (Human), 10%)

      Completed
      • Primary Immunodeficiency Diseases (PID)
      • Immune Globulin Intravenous (Human), 10%
      • Los Angeles, California
      • +8 more
      Apr 29, 2021

      Primary Immunodeficiency, PID Trial in Pittsburgh (CD3/CD19 neg allogeneic BMT)

      Active, not recruiting
      • Primary Immunodeficiency
      • PID
      • CD3/CD19 neg allogeneic BMT
      • Pittsburgh, Pennsylvania
        Children's Hospital of Pittsburgh of University of Pittsburgh Me
      Oct 6, 2021

      Primary Immunodeficiency Disease Trial in Hungary, Italy, Slovakia (Kedrion IVIG 10%)

      Recruiting
      • Primary Immunodeficiency Disease
      • Kedrion IVIG 10%
      • Budapest, Hungary
      • +8 more
      Jun 21, 2021

      Primary Immunodeficiency Diseases (PID) Trial in Canada, United States (Recombinant human hyaluronidase (rHuPH20)+ immune

      Completed
      • Primary Immunodeficiency Diseases (PID)
      • Recombinant human hyaluronidase (rHuPH20)+ immune globulin intravenous (IGIV)
      • Cypress, California
      • +13 more
      Apr 30, 2021

      Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

      Recruiting
      • Primary Immunodeficiency (PID)
      • +4 more
      • data collection
      • Pittsburgh, Pennsylvania
        UPMC Children's Hospital of Pittsburgh
      Feb 9, 2022

      Suppurative Lung Disease in Children and Adults

      Recruiting
      • Primary Ciliary Dyskinesia
      • +2 more
      • Genetic Testing for PCD or PID
      • Unaffected Family Member Genetic Testing
      • Palo Alto, California
      • +7 more
      Mar 30, 2022